Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Acho

Surgery Rochester Hills, MI Doctor of Osteopathy

NPI 1932631314 CMS profile 3674955

75 Barclay Cir Ste 200, Rochester Hills, MI 48307

Open in the dashboard

General payments

$55,539

147 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Acho of Rochester Hills, MI is reported in the CMS Open Payments database as having received $55,539 across 147 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $32,030 34
2024 General $18,511 59
2023 General $804 11
2022 General $311 7
2021 General $131 2
2020 General $385 3
2019 General $3,367 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Acho
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Robert Acho were reported at $32,030. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Robert Acho Surgery median Middle half National median
2019 $3,367 $253 $82–$1,521 $163
2020 $385 $131 $40–$706 $114
2021 $131 $168 $50–$904 $132
2022 $311 $224 $76–$1,218 $149
2023 $804 $253 $82–$1,255 $160
2024 $18,511 $279 $90–$1,381 $164
2025 $32,030 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $52,599 112 payments
  2. Davol Inc. $1,529 16 payments
  3. W. L. Gore & Associates, Inc. $274 2 payments
  4. Ethicon US, LLC $251 4 payments
  5. Covidien LP $226 1 payment
  6. C. R. Bard, Inc. & Subsidiaries $177 3 payments
  7. Integra LifeSciences Corporation $175 3 payments
  8. Janssen Pharmaceuticals, Inc $133 2 payments
  9. Medtronic, Inc. $123 1 payment
  10. ConvaTec Inc. $20 1 payment
  11. Other $32 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $41,520 12 payments
  2. Food and Beverage $6,884 107 payments
  3. Travel and Lodging $4,626 22 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,500 5 payments
  5. Gift $9 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $51,099 111 payments
  2. DAVINCI XI $1,500 1 payment
  3. PHASIX $1,295 11 payments
  4. ProGrip $226 1 payment
  5. MONOCRYL $205 2 payments
  6. GORE SEAMGUARD Bioabsorbable Staple Line Reinforce $186 1 payment
  7. Integra Recon-Skin And Wound $175 3 payments
  8. Integra Recon-Skin And Wound $175 3 payments
  9. INTEGRA DERMAL REGENERATION TEMPLATE $175 3 payments
  10. XARELTO $133 2 payments
  11. Other $1,537 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

58

Median for General Surgery: 59

Drug cost

$95

Median for General Surgery: $393

Branded share of claims

0%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 16 $53
Oxycodone Hcl Generic 25 $21
Ibuprofen Generic 17 $20

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$82,682

Medicare's payments for the services billed

Medicare patients

260

Average age 76

Services billed

657

151 women, 109 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 69%
Ischemic heart disease 53%
Diabetes 49%
Depression 44%
Chronic kidney disease 43%
Heart failure 41%
Atrial fibrillation 41%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kcentra
  • CSL Behring $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

147 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record